China, Oct. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical research on the integrated diagnosis and treatment of lung cancer based on targeted FAP'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135080
Registration Time: 2026/10/23
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=288441
Published by HT Digital Content Services with permission from Health Daily Digest....